eQUANT

eQUANT™ generates a 0.5 McFarland equivalent (eMCF) directly from positive blood culture (PBC) for use direct Disk Diffusion AST.

arrow
eQUANT

eQUANT™ generates a 0.5 McFarland equivalent (eMCF) directly from positive blood culture (PBC) for use direct Disk Diffusion AST.

Add RAPID to your standard of care™

eQUANT can reduce the time to actionable results by as much as 24 hours for many common gram-negative organisms recovered in blood cultures.

Why eQUANT
accurate

Acurate

eQUANT has demonstrated a 95% categorical agreement with the Gold Standard.

02 automated

Automated

eQUANT’s 3-step procedure requires less than 5 minutes of hands-on time.

03 compact

Compact

eQUANT’s compact design is ideal for a variety of healthcare settings.

04 easy to implement

Easy to Implement

eQUANT seamlessly integrates into existing workflows.

05 intuitive

Intuitive

eQUANT’s user-friendly interface ensures quick adoption.

06 cost effective

Cost Effective

eQUANT addresses current healthcare economic challenges.

Add RAPID to your standard of care™

eQUANT can reduce the time to actionable results by as much as 24 hours for many common gram-negative organisms recovered in blood cultures.

accurate

Accurate

eQUANT has demonstrated a 95% categorical agreement with the Gold Standard.

02 automated

Automated

eQUANT’s 3-step procedure requires less than 5 minutes of hands-on time.

03 compact

Compact

eQUANT’s compact design is ideal for a variety of healthcare settings.

04 easy to implement

Easy to Implement

eQUANT seamlessly integrates into existing workflows.

05 intuitive

Intuitive

eQUANT’s user-friendly interface ensures quick adoption.

06 cost effective

Cost Effective

eQUANT addresses current healthcare economic challenges.

eQUANT System Workflow*

Simple 3-step procedure. Under 5 minutes hands-on time.

Step 01

3
2

Start by mixing a small aliquot of positive blood culture (PBC) with proprietary reagent into the eTUBE™ consumable.

Answer image alt text

Step 02

3
2

Load the eTUBE consumable into eQUANT instrument.

Answer image alt text

Step 03

3
2

The eMCF is ready in an average of 70 min and ready for downstream disk diffusion AST.

 

Answer image alt text

* For specific instructions, please refer to IFU.

eQUANT System Workflow*

Simple 3-step procedure. Under 5 minutes hands-on time.

Step 01

Start by mixing a small aliquot of positive blood culture (PBC) with proprietary reagent into the eTUBE™ consumable.

Step 02

Load the eTUBE consumable into eQUANT instrument.

Step 03

The eMCF is ready in an average of 70 min and ready for downstream disk diffusion AST.
step 01
step 03
step 02

* For specific instructions, please refer to IFU.

Reduce Time to Actionable Results

Designed for faster turnaround of AST results

Patients with life-threatening bacteremia need the most appropriate antibiotic therapy. Implementing eQUANT in the positive blood culture AST workflow can reduce time to results by up to 24 hours, which could be the crucial difference.

key

Standard PBC AST Workflow

PBC AST workflow with eQUANT

key

Standard PBC AST Workflow

PBC AST workflow with eQUANT

Also see

Explore related topics and additional resources

eQUANT

eQuant

An open, compact and affordable direct-from-PBC sample prep platform that reduces time to actionable result.

Meike Herget, PhD

Co-Founder & CTO
Bio

Oren Knopfmacher, PhD

Co-Founder & CEO
Bio

Eszter Deak, PhD, D(ABMM)

VP Microbiology
Bio

Michael Blitz

Executive VP for Commercial Operations & Business Development
Bio

Creighton Buie, PE

VP of Engineering
Bio

Nitin Rajan, PhD

VP of R&D
Bio

Alexander Mathews

Vice President of Regulatory Affairs & Quality Assurance
Bio

Dana Tasic, JD

VP of Compliance
Bio

Andy Theiss

Head of Algorithm & Data Science
Bio

Jennifer Lloyd

Strategic Advisor
Bio

Avails' Technology

Our advanced biosensor technology
is accurate, easily adaptable and accessible in a wide variety of clinical laboratory settings settings.

eQuant

An open, compact and affordable direct-from-PBC sample prep platform that reduces time to actionable result.

Avails' Technology

Our advanced biosensor technology
is accurate, easily adaptable and accessible in a wide variety of clinical laboratory settings settings.